Synonym
Scillarenin; NSC234669; NSC-234669; NSC 234669
IUPAC/Chemical Name
5-((3S,8R,9S,10R,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one
InChi Key
OVUOVMIMOCJILI-KFZANIOBSA-N
InChi Code
InChI=1S/C24H32O4/c1-22-10-7-17(25)13-16(22)4-5-20-19(22)8-11-23(2)18(9-12-24(20,23)27)15-3-6-21(26)28-14-15/h3,6,13-14,17-20,25,27H,4-5,7-12H2,1-2H3/t17-,18+,19-,20+,22-,23+,24-/m0/s1
SMILES Code
C[C@]12CC[C@@H](C=C1CC[C@@H]3[C@@H]2CC[C@@]4([C@@H](C5=COC(C=C5)=O)CC[C@]34O)C)O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
384.52
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Sato N, Muro T. Antiviral activity of scillarenin, a plant bufadienolide. Jpn J Microbiol. 1974 Nov;18(6):441-8. doi: 10.1111/j.1348-0421.1974.tb00832.x. PMID: 4375728.
2: Görlich B, Dürr FH, Wolter J. Mikrobiologische Umsetzungen von 4 -Bufatrienoliden. II. Strukturaufklärung der aus Scillarenin, 3-epi-Scillarenin, 5 -iso-Scillarenin, Scillarenon und Scillaridin mittels Rhizopus-Arten erhaltenen Oxygenierungsprodukte [Microbiological turnover of 4 -bufatrienolides. II. Structure elucidation of the oxygenation products of scillarenin, 3-epi-scillarenin, 5 -iso-scillarenin, scillarenon and scillaridin obtained by rhizopus species]. Justus Liebigs Ann Chem. 1971 Nov;753:116-34. German. doi: 10.1002/jlac.19717530111. PMID: 5139285.
3: Görlich B, Wolter J. Mikrobiologische Umsetzungen von delta-4-Bufatrienoliden. I. Oxygenierung von Scillarenin, 3-epi-Scillarenin, 5beta-iso-Scillarenin, Scillarenon und Scillaridin mittels Rhizopus-Arten [Microbiological turnover of delta 4 bufatrienolides. I. Oxygenation of scillarenin, 3-epi-scillarenin, 5 beta-iso-scillarenin, scillarenon and scillaridin using rhizopus species]. Justus Liebigs Ann Chem. 1971 Nov;753:106-15. German. doi: 10.1002/jlac.19717530110. PMID: 5139284.
4: Mahringer A, Karamustafa S, Klotz D, Kahl S, Konkimalla VB, Wang Y, Wang J, Liu HY, Boechzelt H, Hao X, Bauer R, Fricker G, Efferth T. Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genomics Proteomics. 2010 Jul- Aug;7(4):191-205. PMID: 20656985.
5: Krenn L, Jambrits M, Kopp B. Bufadienolides from Urginea hesperia. Planta Med. 1988 Jun;54(3):227-32. doi: 10.1055/s-2006-962412. PMID: 17265257.
6: Görlich B. I. Umsetzung von Scillarenin mit Rhizopus arrhizus. II. Strukturaufklärung von Umsetzungsprodukten des Scillarenins mit Rhizopus arrhizus [I. Transformation of scillarenin by Rhizopus arrhizus. II. Structure clarification of the scillarenin transformation products of Rhizopus arrhizus]. Planta Med. 1971:Suppl 4:113-26. German. doi: 10.1055/s-0028-1099731. PMID: 5154908.
7: Röder E, Lütz J. Potentielle Radiopharmaka zur Nebennierenszintigraphie, 1. Mitt. Zur Radioiodmarkierung von Tyramin-Derivaten einiger Derivate des Digitoxigenins und Scillarenins [Potential radiopharmaceutical for adrenal gland scintigraphy. 1. Radioiodination of tyramine derivatives of some derivatives of digitoxigenin and scillarenin]. Arch Pharm (Weinheim). 1985 Sep;318(9):837-42. German. doi: 10.1002/ardp.19853180913. PMID: 4084030.
8: Röder E, Lütz J. Potentielle Radiopharmaka zur Nebennierenszintigraphie, 2. Mitt. Zur Radioiodmarkierung von p-Hydroxyphenylderivaten des Digitoxigenins, Dihydrodigitoxigenins und Scillarenins [Potential adrenal gland imaging agents. II: Radioiodination of p-hydroxyphenyl derivatives of digitoxigenin, dihydrodigitoxigenin and scillarenin]. Arch Pharm (Weinheim). 1985 Oct;318(10):882-8. German. doi: 10.1002/ardp.19853181005. PMID: 4084020.
9: Kamano Y, Pettit GR. Transformation of digitoxigenin to scillarenin. J Am Chem Soc. 1972 Nov 29;94(24):8592-3. doi: 10.1021/ja00779a057. PMID: 4638992.
10: Kamano Y, Pettit GR. Bufadienolides. 26. Synthesis of scillarenin. J Org Chem. 1974 Aug 23;39(17):2629-31. doi: 10.1021/jo00931a041. PMID: 4412259.